Literature DB >> 485123

Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.

L Verbist.   

Abstract

The in vitro activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 were compared with those of ampicillin and ticarcillin against 336 Enterobacteriaceae, 109 nonfermenters, 55 Neisseria, and 28 Haemophilus influenzae isolates. Bay k 4999 displayed the largest spectrum of activity and had lower minimal inhibitory concentrations than any of the other penicillins against all of the species tested. Piperacillin showed the same spectrum but was slightly less active than Bay k 4999; it was slightly more effective than mezlocillin against Enterobacteriaceae and fully as active as azlocillin against Pseudomonas. All ureidopenicillins were substantially more active than ampicillin and ticarcillin. Isolates highly resistant to ampicillin or ticarcillin were also less susceptible to the ureidopenicillins.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 485123      PMCID: PMC352806          DOI: 10.1128/AAC.16.2.115

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Mezlocillin: in vitro studies of a new broad-spectrum penicillin.

Authors:  G P Bodey; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

2.  Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.

Authors:  R Wise; A P Gillett; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

3.  In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.

Authors:  K Ueo; Y Fukuoka; T Hayashi; T Yasuda; H Taki; M Tai; Y Watanabe; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

4.  Azlocillin: in vitro studies of a new semisynthetic penicillin.

Authors:  D Stewart; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

5.  Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

6.  Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

7.  In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

  7 in total
  14 in total

1.  Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

Authors:  P A Colaizzi; R E Polk; W J Poynor; A C Raffalovich; E A Cefali; L A Beightol
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  Comparative pharmacokinetics of apalcillin and piperacillin.

Authors:  H Lode; A Elvers; P Koeppe; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

3.  In vitro antimicrobial susceptibility of penicillinase-producing and intrinsically resistant Neisseria gonorrhoeae strains.

Authors:  M S Cohen; M H Cooney; E Blackman; P F Sparling
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

Review 4.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

5.  Use of ureidopenicillins for selection of plasmid vector transformants in Pseudomonas aeruginosa and Pseudomonas putida.

Authors:  D L Day; D Yasinow; J McDonough; C W Shuster
Journal:  J Bacteriol       Date:  1984-03       Impact factor: 3.490

6.  Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

8.  Azlocillin and cefonicid penetration into bone enhanced by probenecid.

Authors:  J T Summersgill; L G Harrod; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

9.  [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].

Authors:  K Bartmann; R Tarbuc
Journal:  Infection       Date:  1982 Nov-Dec       Impact factor: 3.553

10.  Comparative activity of six beta-lactam antibiotics against strains of Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae.

Authors:  L A Soares; C E Melles
Journal:  Infection       Date:  1982       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.